Tracking Medicare news, policy, and coverage changes.
The Trump administration is floating a proposal to establish a permanent framework for the Medicare drug price negotiations, as enabled by the Inflation Reduction Act (IRA).
Read full article →The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court docs suggest the agency has reached an agreement with Optum Rx.
Read full article →Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Read full article →From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read full article →A newly published series of reports calls attention to a dire situation facing millions of women after childbirth — and the solutions that can prevent death from postpartum hemorrhage.
Read full article →(MedPage Today) -- Remote patient monitoring (RPM) programs after hospitalization for sepsis or lower respiratory infection -- an approach increasingly reimbursed for by Medicare -- didn't beat usual follow-up care when it came to increasing...
Read full article →(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
Read full article →(MedPage Today) -- Around this time of year, medical schools are engaging in a 250-year-old annual tradition: they're graduating their latest class of career-ready physicians. It's a deservedly triumphant moment -- the culmination of at least...
Read full article →MA insurers commonly deny requests for post-acute care — but none more frequently than UnitedHealth, Humana and CVS, the HHS OIG said. Insurers were not happy about the findings.
Read full article →The Office of Health Technology and Products is the latest technology development from the CMS as it doubles down on digital tools.
Read full article →The company is working with Nvidia to build a foundation model for clinical conversations, and it scored a strategic investment from drugmaker Eli Lilly, Abridge announced during a sweeping keynote Thursday.
Read full article →States will have to provide more rigorous financial analyses for their Medicaid demonstrations beginning in 2027, according to new federal guidance.
Read full article →